{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Randomized+Controlled+Study&page=53", "query": { "condition": "Randomized Controlled Study", "page": 53 }, "page_size": 10 }, "pagination": { "page": 53, "page_size": 10, "total_count": 15129, "total_pages": 1513, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Randomized+Controlled+Study&page=54&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Randomized+Controlled+Study&page=52&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-26T02:44:30.332Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00308451", "title": "A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Chromium Picolinate (600 mcg Cr+3) + biotin (2 mg)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nutrition 21, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 40, "start_date": "2003-11", "completion_date": "2004-04", "has_results": false, "last_update_posted_date": "2006-03-29", "last_synced_at": "2026-10-26T02:44:30.332Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00308451" }, { "nct_id": "NCT04592380", "title": "Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHF", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dyspnea", "Hypertension", "Acute Heart Failure" ], "interventions": [ { "name": "Stage 1: Clevidipine (double-blinded)", "type": "DRUG" }, { "name": "Stage 1: Placebo (double-blinded)", "type": "DRUG" }, { "name": "Stage 2: Clevidipine (open-label)", "type": "DRUG" }, { "name": "Stage 2: Standard of Care (open-label)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Medicines Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2014-08", "completion_date": "2016-11", "has_results": false, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-10-26T02:44:30.332Z", "location_count": 9, "location_summary": "Montgomery, Alabama • Tucson, Arizona • St Louis, Missouri + 5 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Brooklyn", "state": "New York" }, { "city": "Brooklyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04592380" }, { "nct_id": "NCT02288273", "title": "Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Bydureon", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 239, "start_date": "2014-12", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2017-01-27", "last_synced_at": "2026-10-26T02:44:30.332Z", "location_count": 29, "location_summary": "Anaheim, California • Chino, California • Los Angeles, California + 26 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Chino", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "North Hollywood", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02288273" }, { "nct_id": "NCT06712654", "title": "A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hyperphosphatemia", "Chronic Kidney Disease Requiring Chronic Dialysis", "End Stage Renal Disease on Dialysis" ], "interventions": [ { "name": "AP306 75 mg BID", "type": "DRUG" }, { "name": "AP306 125 mg BID", "type": "DRUG" }, { "name": "AP306 150 mg BID", "type": "DRUG" }, { "name": "AP306 75 mg TID", "type": "DRUG" }, { "name": "AP306 100 mg TID", "type": "DRUG" }, { "name": "AP306 125 mg TID", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "R1 Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 168, "start_date": "2026-06-01", "completion_date": "2027-03-31", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-10-26T02:44:30.332Z", "location_count": 24, "location_summary": "Huntsville, Alabama • Chula Vista, California • Los Angeles, California + 19 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Dimas", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06712654" }, { "nct_id": "NCT02580305", "title": "SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "SUVN-502", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Donepezil", "type": "DRUG" }, { "name": "Memantine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Suven Life Sciences Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 564, "start_date": "2015-09", "completion_date": "2019-11-07", "has_results": true, "last_update_posted_date": "2023-06-09", "last_synced_at": "2026-10-26T02:44:30.332Z", "location_count": 71, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Costa Mesa, California + 56 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02580305" }, { "nct_id": "NCT00088166", "title": "XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Brain Edema", "Brain Tumor" ], "interventions": [ { "name": "hCRF", "type": "DRUG" }, { "name": "placebo hCRF", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celtic Pharma Development Services", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2004-05", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2014-08-13", "last_synced_at": "2026-10-26T02:44:30.332Z", "location_count": 27, "location_summary": "Phoenix, Arizona • Fresno, California • Newport Beach, California + 22 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00088166" }, { "nct_id": "NCT00528905", "title": "Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "AZD3480", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 400, "start_date": "2007-08", "completion_date": "2008-11", "has_results": false, "last_update_posted_date": "2008-11-25", "last_synced_at": "2026-10-26T02:44:30.332Z", "location_count": 66, "location_summary": "Little Rock, Arkansas • Anaheim, California • Cerritos, California + 63 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Escondido", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00528905" }, { "nct_id": "NCT00394173", "title": "Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Irritable Bowel Syndrome With Diarrhea (IBS-D)" ], "interventions": [ { "name": "DNK333", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 180, "start_date": "2006-09", "completion_date": "2007-10", "has_results": false, "last_update_posted_date": "2017-02-27", "last_synced_at": "2026-10-26T02:44:30.332Z", "location_count": 37, "location_summary": "Tucson, Arizona • North Little Rock, Arkansas • Los Angeles, California + 34 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "North Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00394173" }, { "nct_id": "NCT07611305", "title": "ProGo Menopause Wellbeing Study", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Menopause Related Conditions" ], "interventions": [ { "name": "Salmon protein hydrolysate (SPH) powder formulated into a tablet format", "type": "DIETARY_SUPPLEMENT" }, { "name": "Microcrystalline Cellulose", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Hofseth Biocare ASA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "40 Years to 65 Years · Female only" }, "enrollment_count": 100, "start_date": "2026-10", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-10-26T02:44:30.332Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07611305" }, { "nct_id": "NCT01254305", "title": "Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Levomilnacipran ER", "type": "DRUG" }, { "name": "Paroxetine, Sertraline, Citalopram or Fluoxetine.", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 262, "start_date": "2011-04", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2014-08-06", "last_synced_at": "2026-10-26T02:44:30.332Z", "location_count": 20, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Cerritos, California + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01254305" } ] }